About OnyvaxSciencePress ReleasesClinical TrialsCareersContact
Onyvax - oncology vaccines 

Current Press Releases

Archived Press Releases





Press Releases image

Archived Press Releases

October 31, 2008
Onyvax identifies a biomarker profile that could be predictive of response to cancer vaccines

March 17, 2008
Onyvax European Phase IIB Clinical Trial Completes Enrolment

January 14, 2008
Onyvax, UCL and LGC Awarded Grant For a £1.8m Project to Develop Predictive Manufacturing Tools for Cell Based Cancer Vaccines

December 4, 2007
Onyvax Granted Broad US Patent for Lead Prostate Cancer Vaccine

September 26, 2007
Phase IIb clinical trial of Onyvax-P
in early stage prostate cancer initiated in United States

December 11, 2006
Onyvax Phase IIb Clinical Trial of Prostate Cancer Vaccine Underway with the Addition of UK Clinical Centres - Trial Adopted by the UK National Cancer Research Network

November 15, 2006
Vaccine Stimulates Immune System to Fight Cancer

May 8, 2006
Onyvax Raises £8 Million to Advance Development of Prostate Cancer Vaccine

April 3, 2006
Eden Biodesign and Onyvax Limited Announce Biomanufacturing Contract

March 27, 2006
University Of Michigan Researchers Zero-In On CD55

September 14, 2005
Onyvax Granted Broad European Patent For Prostate Cancer Vaccines

June 17, 2005
Onyvax Publishes Results Of Phase II Prostate Cancer Vaccine Showing Significant Steps Towards Delaying Disease Progression

May 16, 2005
Onyvax-P May Significantly Extend Progression Free Survival of Metastatic Prostate Cancer Patients

April 19, 2005
Onyvax-105 Cancer Vaccine Shows Encouraging Clinical Results in Osteosarcoma Patients After Intensive Chemotherapy

February 23, 2005
Onyvax Announces EC Grant
For Cancer Vaccine Research Collaboration

February 21, 2005
Onyvax US Clinical Advisory Board Reviews Phase II Data And Gives Input To Onyvax-P Late-Stage Clinical Trial Design In Prostate Cancer

February 15, 2005
Onyvax appoints Richard de Souza as Non Executive Director

November 17, 2004
Onyvax Discovers Clinical Responses To Prostate Cancer Vaccine Correlate With Immunological Data Analysis

October 29, 2004
Onyvax Announces EC Funded Research Collaboration To Develop New Lung Cancer Treatments

June 17, 2004
Final Phase II Data Shows That Onyvax-P May Significantly Extend Progression Free Survival For Men With Advanced Prostate Cancer

March 29, 2004
Onyvax and University of Michigan Develop PSA Expressing Cell Lines For Prostate Cancer Vaccine Research

March 3, 2004
Onyvax Issued Broad US Patent For Prostate Cancer Vaccines

February 23, 2004
Onyvax Appoints Dr John Brown As Non Executive Director

January 15, 2004
Onyvax and The Mayo Clinic to Develop Cancer Vaccines for Ovarian Cancer

December 10, 2003
Scancell, Onyvax and CRT Announce Agreement to Facilitate the Development of “Immunobody” Cancer Vaccine Technology

September 24, 2003
Berna Biotech and Onyvax announce collaboration

July 3, 2003
Onyvax Presents Interim Phase II Data on its Prostate Cancer Vaccine at the British Cancer Research Meeting

May 6, 2003
Onyvax Presents Preliminary Phase II Data on its Prostate Cancer Vaccine at American Association of Immunologists Annual Meeting

April 14, 2003
Onyvax Completes Enrolment in Phase II Prostate Cancer Clinical Trial

October 14, 2002
Onyvax Appoints J. Barrie Ward as Chairman

October 8, 2002
UK and US Companies Link to Accelerate Prostate Cancer Research

May 30, 2002
Phase II Prostate Cancer Vaccine Trial Set to Expand

January 9, 2002
Phase II Prostate Cancer Vaccine Trial Initiated

November 16, 2000
Onyvax Raises Euro17.5m To Fund Cancer Vaccine Programs

May 24, 2000
Grant of Key Cancer Vaccine Patent in US

May 2, 2000
Initiation of Clinical Trials of Onyvax Colorectal Cancer Vaccines

December 13, 1999
Onyvax Limited, Cancer Research Campaign Technology, Institute of Cancer Research and the Royal Marsden Hospital Announce Initiative in Prostate Cancer Research

June 28, 1999
Erasmus University Rotterdam and Onyvax Announce Collaboration in Prostate Cancer Research

May 11, 1999
Cancer Vaccine Licence from CRCT

March 24, 1999
Award of DTI LINK Grant

February 1999
Vaccine Trial for Prostate Cancer

March 18, 1998
Stanford Rook and Onyvax Collaboration

December 18, 1997
Onyvax Receives Venture Financing



© 1998-2009 Onyvax Ltd. All Rights Reserved